Topics (15) View all

Questions and Answers (5) View all

  • Answer added in Homology Modeling
    57 Can you recommend any homology modeling tools?
    By Priyanka Kshirsagar · Solapur University
    David Watson · University of Mississippi
    You may also want to try out I-tasser for automated homology model development, depending upon your target. 
  • Answer added in Modeling and Docking
    3 What is molecular dynamics and simulation?
    By Prasanna Ranade · University of Mumbai
    David Watson · University of Mississippi
    Molecular dynamics is an atomistic method of simulating the movement of molecules over (usually relatively short) time scales. It is predominantly use... [more]
  • Answer added in Modeling and Docking
    2 How to interpret Docking results?
    By Talal Awad · sudan academy of science
    David Watson · University of Mississippi
    My first question is whether or not you performed a validation with the native ligand, if applicable. Did it dock sufficiently close to the native cry... [more]
  • 9 Can anyone suggest drugs regarding Triazoles and Oxadiazole available commercially?
    By Mohana Rao Katiki · Indian Institute of Chemical Technology
    David Watson · University of Mississippi
    One approach may be to search at drugbank.ca using a SMILES string. There may even be a way to limit the search to approved drugs. 
  • Answer added in QSAR
    4 reliable method for outlier detection and elimination in 3D QSAR CoMFA?
    By Nirzari Gupta · Nirma University
    David Watson · University of Mississippi
    If you intend to reject outliers, there should be justifiable reason to do so, and rejections should be documented. Some outliers can provide valuable... [more]

Publications (2) View all

  • Article: Pharmacokinetics and excretion of gamma-hydroxybutyrate (GHB) in healthy subjects.
    [show abstract] [hide abstract]
    ABSTRACT: In Europe and the United States, the recreational use of gamma-hydroxy butyric acid (GHB) at dance clubs and "rave" parties has increased substantially. In addition, GHB is used to assist in the commission of sexual assaults. The aim of this controlled clinical study was to acquire pharmacokinetic profiles, detection times, and excretion rates in human subjects. Eight GHB-naïve volunteers were administered a single 25-mg/kg body weight oral dose of GHB, and plasma, urine, and oral fluid specimens were analyzed by using gas chromatography-mass spectrometry (GC-MS). Liquid-liquid extraction was performed after acid conversion of GHB to gamma-butyrolactone. Limits of quantitation of 0.1 (oral fluid), 0.2 (urine), and 0.5 microg/mL (plasma) could be achieved in the selected ion monitoring mode. GHB plasma peaks of 39.4 +/- 25.2 microg/mL (mean +/- SEM) occurred 20-45 min after administration. The terminal plasma elimination half-life was 30.4 +/- 2.45 min, the distribution volume 52.7 +/- 15.0 L, and the total clearance 1228 +/- 233 microL/min. In oral fluid, GHB could be detected up to 360 min, with peak concentrations of 203 +/- 92.4 microg/mL in the 10-min samples. In urine, 200 +/- 71.8 and 230 +/- 86.3 microg/mL, were the highest GHB levels measured at 30 and 60 min, respectively. Only 1.2 +/- 0.2% of the dose was excreted, resulting in a detection window of 720 min. Common side-effects were confusion, sleepiness, and dizziness; euphoria and change of vital functions were not observed. GHB is extensively metabolized and rapidly eliminated in urine and oral fluid. Consequently, samples should be collected as soon as possible after ingestion.
    Journal of analytical toxicology 28(8):625-30. · 2.02 Impact Factor
  • Article: Highly selective hydrolysis of kinins by recombinant prolylcarboxypeptidase.
    [show abstract] [hide abstract]
    ABSTRACT: We have previously cloned a cDNA encoding human prolylcarboxypeptidase (PRCP) and expressed the cDNA in the Schneider 2 (S2) drosophila cell line. Here, we further characterized this recombinant enzyme. Investigations were performed to determine whether recombinant PRCP (rPRCP) metabolizes kinins (BK 1-9 and BK 1-8). The metabolites of these kinins were identified by LC/MS. rPRCP metabolized BK 1-8 to BK 1-7, whereas rPRCP was ineffective in metabolizing BK 1-9. The hydrolysis of BK 1-8 by rPRCP was dose- and time-dependent. A homology model of PRCP was developed based upon the sequence of dipeptidyl-peptidase 7 (DPP7, PDB ID: 3JYH), and providentially, the structure of PRCP (PDB ID: 3N2Z) was characterized during the course of our investigation. Docking studies of bradykinin oligopeptides were performed both from the homology model, and from the crystal structure of PRCP. These docking studies may provide a better understanding of the contribution of specific residues involved in substrate selectivity of human PRCP.
    Biochemical and Biophysical Research Communications 02/2011; 405(3):338-43. · 2.48 Impact Factor

Following (28) See all

Followers (25) See all